Apyx Medical (APYX) Depreciation & Amortization (CF) (2011 - 2026)
Apyx Medical (APYX) posted Depreciation & Amortization (CF) of $202000.0 for Q1 2026, down 8.6% on a QoQ basis from $221000.0 in Q4 2025, and up 46.38% year-over-year from $138000.0 in Q1 2025.
Apyx Medical (APYX) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
Apyx Medical's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $202000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 46.38% year-over-year to $202000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $719000.0 (up 23.97% YoY) and the FY2025 annual result came in at $655000.0, up 9.35% from the prior year.
- Depreciation & Amortization (CF) was $202000.0 for Q1 2026 at Apyx Medical, down from $221000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $247000.0 in Q2 2022 and bottomed at $132000.0 in Q2 2025.
- A 5-year average of $178705.9 and a median of $164000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 38.87% — and 2025, when it surged 55.63%.
- Apyx Medical's Depreciation & Amortization (CF) stood at $202000.0 in 2022, then retreated by 24.75% to $152000.0 in 2023, then dropped by 6.58% to $142000.0 in 2024, then jumped by 55.63% to $221000.0 in 2025, then slipped by 8.6% to $202000.0 in 2026.
- Business Quant data shows APYX's Depreciation & Amortization (CF) at $202000.0 in Q1 2026, $221000.0 in Q4 2025, and $164000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 67.10 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Apyx Medical | 168.63 Mn | 137.49 Mn | 7.93 Mn | 202,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | 221,000.00 |
| Dec 31, 2025 | 221,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Sep 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 132,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 142,000.00 |
| Dec 31, 2024 | 142,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Jun 30, 2024 | 156,000.00 |
| Mar 31, 2024 | 157,000.00 |
| Mar 31, 2024 | 157,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |